UNSPSC 51334101: Isosulpride

This classification denotes a serotonin antagonist and dopamine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BRT31Y0N0K. European Medicines Agency schedules Isosulpride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08338MIG. Isosulpride generally arises in the molecular formula C15H23N3O4S.

UNSPSC 51334101 Isosulpride is a Commodity code that, based on recent state and local procurement activity, does not see solicitation for the pharmaceutical product its name suggests. The single identifiable recent opportunity tagged to this code—Seminole County, Florida's IFB for Naloxone and drug deactivation systems—involves procurement of opioid-reversal medication and harm-reduction equipment, which falls outside the scope of isosulpride, an antipsychotic drug. The mismatch between the code's nominal scope and the actual work being solicited suggests either a data-entry error or systematic miscoding in the source, and this code shows little relevant recent activity for vendors seeking state and local pharmaceutical or medical-supply procurement aligned with isosulpride distribution.

Seminole County released its Naloxone and Safe Drug Deactivation Systems IFB on July 10, 2026 (posted June 30, 2026) with a response deadline of July 26, 2023—an internal date inconsistency in the source record itself. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida, with a two-year initial term and one-year renewal option. Vendors were required to submit bids electronically, include all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, comply with E-Verify and drug-free workplace requirements, and pass a three-month probationary period. No explicit set-aside designations were noted. Business development professionals should treat this code as inactive for isosulpride procurement and verify correct coding before pursuing state or local opportunities in pharmaceutical supply.